1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > Dual Chamber Syringes & Injectors to 2022

Dual Chamber Syringes & Injectors to 2022

  • September 2015
  • -
  • Greystone Research Associates

Summary

In terms of formulation market share gains, lyophilized injectable drugs are the fastest growing drug formulation segment. From 1990 to 1998 the share of newly approved lyophilized drugs as a share of all injectable/infusible drugs was 11.9%. In 2011, it was 41% and in 2013, injectable/infusible drugs requiring reconstitution made up half of all new approvals. Because a significant number of these drugs are developed for self-administration, they present special challenges for developers. Dual chamber syringes & injectors – designed to simplify reconstitution without patient handling of drug or diluent – have become the mainstay delivery option for this class of drugs. As lyophilized injectables continue to increase in number and market share, dual chamber syringes and injectors will experience double-digit annual unit growth.

What You Will Learn

-What are the currently marketed dual chamber syringes and injection devices and what is their impact on markets for therapeutic injectable lyophilized drugs?
-What are the therapeutic demand drivers for user-friendly point-of-use reconstitution devices and what specifically is the potential of dual chamber syringes and injector systems?
-What are the key dual chamber device selection factors, technologies and market development issues?
-What doses the current dual chamber device market look like, who are the market leaders, and what will this market look like in 2022?
-What companies supply dual chamber syringe and injector devices, and what are their product activities, business strategies, and corporate alliances and affiliations?
-How important are pharma-device alliances and design partnerships on dual chamber injection devices?
-What is the impact of economic, technology, and regulatory factors?

Table Of Contents

Dual Chamber Syringes and Injectors to 2022
Executive Summary
Injectable Drug Market Dynamics

Evolution in Device Design
Formulation Factors
Product Specific Device Development
Specialty Injection Device Demand Drivers
Chronic Conditions and Self-Administration
The Growth of Biologicals
Formulation and Dosing
Shifting Patient Demographics
Drug Economics, Safety and Compliance
Device Design and Innovation
Competitive Landscape
Technology Market DriversThe Dual Chamber Injection Device Ecosystem

Dual Chamber Cartridges
Dual Chamber Injectors
Dual Chamber Syringes

Dual Chamber Syringe and Injector Device Assessments

Product-Specific Devices
Specialty Devices
OEM Devices

Therapeutic Segments - Market Data and Forecasts

Glycemic Control
Hereditary Conditions
Hormone Replacement
Infectious Disease
Metabolic Conditions
Oncology
Reproductive Health
Other Therapeutic Segments

Market Factors

Device Product Strategies
Device Economics
Product Branding
Direct-to-Consumer Marketing
Managed Care Trends

Company Profiles

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
European Market Report for Peripheral Intravenous Catheters 2017 - MedCore

European Market Report for Peripheral Intravenous Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European PIVC market includes three segments: conventional PIVCs, safety PIVCs and midlines. The safety PIVC segment includes three sub-segments: active safety PIVCs, passive safety PIVCs ...

BRIC Insulin Delivery Market Outlook to 2022

BRIC Insulin Delivery Market Outlook to 2022

  • $ 5995
  • Industry report
  • January 2017
  • by Global Data

BRIC Insulin Delivery Market Outlook to 2022 Summary GlobalData’s new report, "BRIC Insulin Delivery Market Outlook to 2022", provides key market data on the BRIC Insulin Delivery market. The report ...

Asia-Pacific Insulin Delivery Market Outlook to 2022

Asia-Pacific Insulin Delivery Market Outlook to 2022

  • $ 5995
  • Industry report
  • January 2017
  • by Global Data

Asia-Pacific Insulin Delivery Market Outlook to 2022 Summary GlobalData’s new report, "Asia-Pacific Insulin Delivery Market Outlook to 2022", provides key market data on the Asia-Pacific Insulin Delivery ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.